These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6112021)

  • 1. Piperidine in chronic schizophrenic patients: a controlled double-blind study.
    Luchins DJ; Gillin JC; Wagner RL; DeLisi LE; Morihisa JM; Weinberger DR; Bigelow LB; Klein ST; Wyatt RJ
    Biol Psychiatry; 1981 Jan; 16(1):91-5. PubMed ID: 6112021
    [No Abstract]   [Full Text] [Related]  

  • 2. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 4. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
    Donlon PT; Meyer JE
    J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
    Deutsch M; Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 8. A preliminary study with penfluridol in hospitalized chronic schizophrenic patients.
    Rousos AP; Hargrave R
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):618-26. PubMed ID: 812638
    [No Abstract]   [Full Text] [Related]  

  • 9. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
    Lee BJ; Lee JG; Kim YH
    J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI; Barron A; Kiriakos R
    J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pimozide and social rehabilitation of chronic schizophrenic patients].
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Encephale; 1972; 61(1):53-66. PubMed ID: 4561271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of NOSIE in the study of neuroleptic treatment].
    Li Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):325-7. PubMed ID: 3329087
    [No Abstract]   [Full Text] [Related]  

  • 17. A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):20-1. PubMed ID: 329325
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 19. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.